NMPA Approval

Ombitasvir,Paritaprevir and Ritonavir Tablets

Approval Number

H20181131

Registration Date

March 2, 2018

Previous Approval Numbers

H20170366

Drug Information

Generic Name

奥比帕利片

Trade Name

维建乐

Dosage Form

片剂

Drug Type

化学药品

Registration Date

March 2, 2018

Expiry Date

September 19, 2022

Company Address

Maidenhead SL6 4UB,United Kingdom

Company Address

Anngrove, Carrigtwohill, Co. Cork, Ireland

Empowering clinical research with data-driven insights and AI-powered tools.

奥比帕利片 - NMPA 批准文号 | MedPath